CLICK TO EXPAND

News About DC

IN THIS DAY AND AGE, NEWS TRAVELS FASTER THAN EVER BEFORE.

And when it’s about Dunlap Codding, our team and our accomplishments, it all lands right here.
Jordan Sigale, Dunlap Codding Director, Quoted Extensively in Bloomberg BNA
Posted May 23, 2015 at 9:08 am See More

Bloomberg BNA’s Patrent, Trademark & Copyright Journal quoted Jordan Sigale in a May 22, 2015, article on copyrights and copyrightability, “En Banc ‘Innocence of Muslims’ Ruling Says Actor Didn’t Hold Copyright in Film.”

In Garcia v. Google, Inc., 9th Cir., No. 12-57302, 5/18/15, the U.S. Court of Appeals for the Ninth Circuit, sitting en banc, ruled 10-1 that the actor (allegedly tricked into appearing in an anti-Muslim firm) didn’t hold a copyright interest in her performance separate from the work as a whole.  The court reversed a ruling by a prior judicial panel, saying that the YouTube posting ,which had led to death threats, was protected by the First Amendment.  “The 2014 ruling by Judge Alex Kozinski had been widely criticized both by free speech advocates and by the motion picture industry,” noted Bloomberg, further observing that many copyright scholars and practitioners had predicted that Kozinski’s ruling would not survive.  But Bloomberg said some practitioners were surprised by the scope of the en banc ruling.

Sigale noted that the recent court’s ruling was a surprise in terms of scope, and was quoted as saying, “The Ninth Circuit did not need to reach the merits of the copyright claim.”  Sigale referred to a concurring opinion in the matter and noted that the court could have ruled based on the requirements for granting an injunction.  “Kozinski’s prior ruling was immediately dissolved by the en banc panel’s ruling.  However, Judge Kozinski and the unfortunate issues created by the majority opinion on copyright authorship are not going away…..Copyright law in the Ninth Circuit has been weakened by this decision.  I hope with the passage of time, litigants will see this opinion as being limited to its specific facts and move past it.”

With regard, however, to Kozinski’s point that a musician is not required to record his own music in order to hold rights in it, Sigale agreed and said, “Moreover, copyright law recognizes the separate performance rights in the various members of a band (e.g. vocalists, guitarists, drummer) as well as the producer of the sound recording….Similar concerns can and should be raised by choreographers and the like, whose contributions to larger works had long been recognized.  This opinion calls all of that into question.”

Douglas J. Sorocco Quoted in MainStreet Regarding a $100 Million Lawsuit
Posted May 21, 2015 at 10:29 am See More

Dunlap Codding Shareholder Doug Sorocco was quoted in a May 18, 2015, article by Juliette Fairley in MainStreet, “Dispute Over Posting of Hemp Test Results Leads to $100 Million Lawsuit By MJNA.”  The article explains that “MJNA, a publicly traded company, is seeking damages for comments about significant levels of toxic solvents that reportedly harmed its reputation and stock price.”  Sorocco is quoted as noting that, “A significant portion of hemp oil available in the market is obtained from industrial manufacturing and there is a concern in the industry that the industrial processes may introduce an unacceptable level of heavy metals into hemp oil.” 

Elizabeth Lauderback Quoted in the Oklahoma Gazette
Posted May 20, 2015 at 15:41 pm See More

Dunlap Codding associate Elizabeth Lauderback was quoted in the Oklahoma Gazette in an article by Ben Felder, “IgniteOKC offers 13 presenters 6 minutes each to share rapid-fire, TED-like talks,” May 20, 2015.  Elizabeth is the chair of Ignite OKC 8. 

Elizabeth was quoted as saying, “There is a lot of breathing room here for a lot of average people who have a passion and want to do something creative….We are a growing city, but we are not saturated…so you can be the movement here as opposed to just being part of it….IgniteOKC is all about igniting a community, and OKC is in a state of ignition and growth right now, so it is very timely.”

Dunlap Codding Ranked in Band 1 for Intellectual Property by Chambers USA: America’s Leading Lawyers for Business
Posted May 20, 2015 at 9:21 am See More

OKLAHOMA CITY, OKLAHOMA—May 19, 2015—Dunlap Codding is pleased to be ranked in Band 1 (the top band) for intellectual property by Chambers USA: America’s Leading Lawyers for Business. The publication is widely regarded as the most reliable and intensively researched of all lawyer rating directories. Chambers USA began ranking Oklahoma Intellectual Property firms in 2010. Dunlap Codding has been a top-ranked firm since the inaugural coverage of the state’s intellectual property practitioners, and is again ranked in Band 1 for 2015.

Chambers quotes sources as saying, “A fantastic team – and the first set of lawyers we’ve used with a cooperative, problem-solving attitude,” and, “Their real strong point is thinking outside the box to get the goal accomplished…..”

Chambers described the firm as a “Heavy-hitting boutique servicing the full range of copyright, patent and trademark concerns for clients at every level, from local startup to foreign multinational. Noted for its litigation capability and its strong focus on life sciences, healthcare, electrical engineering and computer technology. Significant clients [include] Ashland, DePuy Synthes, DuPont/EKC Technology, Quibids, and Siemens Healthcare Diagnostics.” 

Chambers said, “Managing director Nicholas Rouse attracts client praise for his knowledge of mechanical engineering issues. He acts most frequently on patent and trademark prosecution and portfolio management.” 

Chambers also said, “Marc Brockhaus heads the electrical engineering and systems group and recently advised consumer electronics retailer Petra Industries on its involvement in a patent infringement action. Sources testify to his winning combination of technical and technological know-how and keen commercial awareness.” 

Finally, Chambers wrote, “Douglas Sorocco leads the practice and is appreciated by clients, not only for his “very valuable skill set” and determination “to work out a way of making sure problems get solved,” but also because “he’s really concerned about how we feel about things.” He is notably active in life sciences and technology, and recently counseled titanium dioxide product manufacturer Cristal USA on the creation of a Swiss holding company, associated licensing agreements and ongoing patent portfolio matters.” 

Dunlap Codding, with offices in Austin, Chicago, Oklahoma City, and Washington, D.C., serves sophisticated international, national, and regional clients.  Established in 1957 as Oklahoma’s original intellectual property firm, Dunlap Codding remains the region’s largest and most versatile IP boutique providing counsel in the areas of patent, trademark, copyright, and entertainment law as well as related litigation and licensing services. 

Dunlap Codding Shareholder Emily E. Campbell Quoted in an Article on Copyright Office Inquiry into Licensing of Photos, Illustrations
Posted May 1, 2015 at 9:41 am See More

Emily Campbell was quoted extensively in an April 28, 2015, Bloomberg BNA article published by The Bureau of National Affairs, Inc., written by Anandashankar Mazumdar.  The article summary stated, “The Copyright Office is reviewing how certain visual works, particularly photographs, graphic artworks, and illustrations, are monetized, enforced, and registered under the Copyright Act.”

The Federal Register, on April 24, had published the Office’s call for public comments on obstacles facing creators of visual works in monetizing their creations.  Emily was quoted as saying that the process seemed “like medicine, where we are trying to take preventative steps to maintaining our health.  It seems like the Copyright Office is trying to take preventative measures to protect rights with regard to digital images.”  Typically, those holding copyright interest in visual works have had only reactive measures to turn to, such as relying on “copyright enforcement groups out there enforcing rights of third parties.”  Emily commented that the initiative was a good start in prompting thinking about how to protect rights from the beginning.

The article noted that, according to the notice, “Even when creators of visual works successfully license use of their works, the resulting uses can result in their credit information and other embedded copyright management data being stripped away.”

Emily explained that copyright holders, their lawyers and potential users or licensees of visual works do not currently have access to a comprehensive, centralized database of visual works. 

“Currently there’s a database that’s in place, but copyright law has always had a challenge of chasing technology,” Campbell said. “So we face these issues of trying to conduct a search on the Library of Congress site and we face a limitation in that we can’t view the works.”

Emily suggested that something akin to the Creative Commons database would be helpful in overcoming some of the obstacles faced.

Douglas J. Sorocco Guest Blogs on Thomson Reuters Legal Current
Posted Apr 29, 2015 at 12:07 pm See More

Fish Are Friends, Not Food. What About Sharks, Can They Be A Trademark?

While Katy Perry’s ongoing attempt to conquer and rule all things “shark” has run into a couple of snafus the last couple of weeks, one thing is for certain: This battle is not the Waterloo being heralded by many Internet commandos.

The Internet’s angst has arisen by Ms. Perry’s attempts to obtain trademark protection covering the antics of one of her backup dancers during the 2015 Super Bowl halftime show who appeared a bit out of step with the famous singer.

To read the full post, with video and visuals, click Fish Are Friends, Not Food.  Or, here is a downloadable pdf.

Douglas J. Sorocco is a director and shareholder at Dunlap Codding. He practices in the areas of intellectual property, technology, licensing, life sciences and patent law and is involved in counseling and transactional work involving all aspects of intellectual property. He is registered to practice before the United States Patent and Trademark Office.

The New World of Patent Post-Grant Proceedings—Dunlap Codding Article Featured in Paradigm Magazine
Posted Apr 1, 2015 at 13:29 pm See More

Dunlap Codding Associates Ann Robl and Lewis Craft co-authored an article published in the Spring 2015 issue of Paradigm, the magazine of the International Society of Primerus Law Firms.  The article, “The New World of Patent Post-Grant Proceedings:  Positioning Your Company to Win,” addresses the rising popularity and pitfalls of patent post-grant proceedings. 

Ann focuses her practice in the areas of patent post-grant proceedings, patent drafting, patent prosecution, patentability analyses, infringement analyses, prior art searching, and technology licensing.  Lewis concentrates his practice in the areas of drafting and prosecuting patent applications, patentability analyses, prior art searching, invalidity opinions, freedom-to-operate opinions, post-grant proceedings, and technology licensing.

MCCA Names Dunlap Codding Shareholder Douglas J. Sorocco A Minority Rainmaker
Posted Mar 5, 2015 at 13:35 pm See More

OKLAHOMA CITY, OKLAHOMA – March 5, 2015 – Dunlap Codding is pleased to announce that Douglas J. Sorocco, who was born with spina bifida, was one of 15 minority rainmakers recently selected by MCCA (Minority Corporate Counsel Association) for inclusion in its annual, nationwide list and featured in Diversity & The Bar.  

MCCA was founded in 1997 to advocate for the expanded hiring, retention, and promotion of minority attorneys in corporate law departments and the law firms that serve them. Dunlap Codding is unusual among intellectual property law firms, typically composed largely of male attorneys with engineering degrees, in that over fifty percent of its fee-earning professionals are females. The firm is committed to advancing diversity and inclusion in the legal profession as evidenced by its membership in and support of the MCCA’s Firm Affiliate Network (FAN). Dunlap Codding is the only Oklahoma law firm member of FAN. 

Dunlap Codding P.C., with offices in Austin, Chicago, Oklahoma City, and Washington, D.C., serves sophisticated international, national, and regional clients.  Established in 1957 as Oklahoma’s original intellectual property firm, Dunlap Codding remains the region’s largest and most versatile IP boutique providing counsel in the areas of patent, trademark, copyright, and entertainment law as well as related litigation and licensing services. 

Dunlap Codding Director Jordan Sigale Named a 2015 Illinois Super Lawyer
Posted Jan 29, 2015 at 8:14 am See More

CHICAGO, ILLINOIS – January 21, 2015 – Dunlap Codding is pleased to announce that Jordan Sigale has been selected by attorney peers for inclusion in Illinois Super Lawyers 2015 for Intellectual Property Litigation and for Intellectual Property.  Sigale has been listed as a Super Lawyer since 2014 for Intellectual Property, Intellectual Property Litigation, and for Media Law. 

Jordan Sigale practices in intellectual property, computer and patent law with a focus on patent and trade secret litigation and alternative dispute resolution. His work also extends to client counseling on issues of corporate and strategic planning involving copyrights, patents, trademarks, and trade secrets. He is extensively involved in patent prosecution for a variety of clients with specific focus on the interface between computers and end-users in an array of situations and transactions. 

Jordan has served as lead litigation and trial counsel in district courts throughout the U.S. involving a variety of intellectual property issues including computer intrusion, copyright infringement, false advertising, design and utility patent infringement, trade secret misappropriation and trademark infringement. He has also served as lead litigation and trial counsel on a variety of antitrust claims, usually focused on the antitrust – intellectual property interface. Jordan has been extensively involved in coordinating foreign intellectual property litigation strategy in Australia, China, Europe, and Hong Kong. 

Dunlap Codding P.C., with offices in Austin, Chicago, Oklahoma City, Wilmington, and Washington, D.C., serves sophisticated international, national, and regional clients.  Established in 1957 as Oklahoma’s original intellectual property firm, Dunlap Codding remains the state’s largest and most versatile IP boutique.  For the past 50 years, the firm has obtained more patents, trademarks, and copyrights than any other firm in the region.

Dunlap Codding Senior Associate Julie L. Langdon Named an Illinois Rising Star 2015
Posted Jan 29, 2015 at 8:11 am See More

CHICAGO, ILLINOIS – January 21, 2015 – Dunlap Codding is pleased to announce that Julie L. Langdon has been named to the IllinoisRising Stars 2015 list for Intellectual Property Litigation as one of the top up-and-coming attorneys in Illinois. Each year, no more than 2.5 percent of the lawyers in a state receive this honor.  Langdon has been listed as a Rising Star since 2012. 

Langdon’s practice encompasses a number of areas of intellectual property law, including litigation, licensing, counseling, and asset prosecution. Her primary practice is patent litigation with a concentration in the areas of biotechnology and life sciences, chemical, and pharmaceutical arts, including Hatch-Waxman issues. She represents plaintiffs and defendants in patent-related litigations involving infringement and other disputes arising over patent rights.  She also has experience with trademark portfolio protection and maintenance before the USPTO and international bodies. Prior to joining Dunlap Codding in 2015, Langdon was an associate attorney at Loeb & Loeb LLP and at Ladas & Parry LLP.  

Dunlap Codding P.C., with offices in Austin, Chicago, Oklahoma City, Wilmington, and Washington, D.C., serves sophisticated international, national, and regional clients.  Established in 1957 as Oklahoma’s original intellectual property firm, Dunlap Codding remains the state’s largest and most versatile IP boutique.  For the past 50 years, the firm has obtained more patents, trademarks, and copyrights than any other firm in the region.

CLICK TO EXPAND

DC On Film Row

About DC on Film Row

DC on Film Row is a free event space open to everyone in our community.

We like to say that the space is a “home for creatives and innovators, home builders and the homeless, celebrators and the celebrated” so people understand that we are inclusive and want everyone from throughout our community using our space.

Our goal is to celebrate the incredible diversity of creativity, innovation, and passion within Oklahoma City and to provide a venue—free of charge—to those groups and individuals working to bind us all together and make our home a cooler and better place. No strings attached—no extensive rules to follow. We simply ask that all of our neighbors be honored and that all viewpoints be respected. Our criteria for use is simple: If the event, group, or meeting is something which strengthens our community and brings us all together, the space is available for use.

The space has hosted everything from charitable fundraisers to an underground nightclub party to celebrate Canterbury Choral Society’s 45th anniversary season. We host dinners for the OKC homeless population most Monday evenings where upwards of 250 people are served—we provide the space and soft drinks and a local church provides the food. We’ve hosted university planning retreats and monthly local rock concerts.

Every Wednesday, we open up the courtyard for lunch, invite a local food truck to set up outside our gates, and welcome our downtown neighbors into the space for a bit of socialization.

Our never-ending soda fountain seems to be the biggest hit with some of our neighbors while others spend time playing pool or simply chatting about what is happening on the weekend.

For October we turn the space into a haunted house and invite the neighborhood children to come out and trick-or-treat.

Got an idea for how to use the space? Just ask us – we’re almost certain to say yes!

Twitter Instagram Facebook

Industries Served

Biotechnology

LIFE SCIENCES AND BIOCHEMISTRY
Leveraging Patent Portfolios

Our professionals routinely assist legacy and start-up companies in the acquisition and exploitation of patent portfolios of cutting edge research in the areas of pharmaceuticals, drug formulation, medical technology, drug screening, inflammation inhibitors, regulation of skin pigmentation, testing for environmental pollution, novel treatments of septic shock, and water and food quality testing.  We have an exceptional track record in identifying and protecting inventions involving:

  • Pain regulation
  • Tissue grafting
  • Cloning/gene expression/protein production, isolation and characterization
  • Cell surface expressional
  • Medical/surgical anesthetic devices
  • Biocidal formulations and coatings
  • Toxicity screening
  • Enzymatic activity assays
  • Drug delivery systems
  • Developing Portfolio Strategy

We believe that a pragmatic and strategic approach is necessary to ensure that every portfolio is strong on defense as well as on offense. Whether it is a core, a platform, a fence-picket or a poker-chip technology, Dunlap Codding has the depth of experience and tools necessary to help our clients determine whether it is an asset or simply just an expense.

Chemistry and Chemicals

Chemistry is one of the fundamental foundations of science and technology. Emerging chemical research and experimentation continually produce innovations that shape the field of raw materials and affects the lives of every person on the planet.

Dunlap Codding is fortunate to work with and contribute to the success of many of the leading researchers and entrepreneurs in these areas. From nano-fibers to synthetic and recombinant polymers, Dunlap Codding consistently provides clients with broad-based, cost-effective patent prosecution in the chemical arts.

The depth of our skill and experience is unmatched in our region. We represent several of the largest chemical companies in the world and have shepherded the development of complex patent portfolios and transactional items.

Selected Clients

Invista S.a.r.l. is one of the world’s largest integrated fibers and polymers businesses. The company has a powerful portfolio of some of the most recognized global brands—Lycra®, Stainmaster®, Cordura®—for example. Built on a heritage of innovation, Invista owns more than 700 unique pending or granted U.S. patents, with corresponding patents in nearly all the countries where they have a business presence. We were honored to be one of Invista’s preferred providers of intellectual property services supporting their chemical intermediates and performance fiber initiatives. As part of these efforts, we wrote and prosecuted patents on hundreds of Invista technologies and provided strategic planning and facilitated innovation services to maintain Invista’s technological lead. Notably, Invista relied on our chemical engineering and chemistry expertise for transactional matters requiring complex reviews of freedom to operate, infringement, and invalidity concerns. Recently we provided Invista with the due diligence analysis and opinions required for the placement and construction of a chemical plan requiring a capital investment of more than $1 billion dollars.

Cristal USA Inc. is the United States arm of Cristal Arabia, one of the largest titanium dioxide and performance chemicals producers in the world. As part of our representation of Cristal, we are responsible for the strategic development and management of Cristal’s intellectual property portfolio, including the patent assets of Millennium Inorganic Chemicals—a wholly owned subsidiary of Cristal. Cristal and Millennium’s technologies encompass titanium dioxide, titanium metal, performance chemicals, and DeNOx technologies for removing nitrous oxide from the exhaust of internal combustion engines. We have developed a proprietary process for the identification of patenting opportunities, and use the process in facilitated sessions with technical and business personnel of Millennium. This proprietary process currently tracks more than 100 companies and approximately 1,000 intellectual property documents.

We work with DuPont Performance Elastomers to facilitate the development of new technologies and patenting strategies around DPE’s core elastomer technologies. In addition to such strategic planning, we provide assistance and guidance to DuPont’s in-house legal staff and technical champions.

Technology Focus:
Nanotechnology

We obtained multiple patent families for Dr. Daniel Resasco, a University of Oklahoma professor of chemical engineering. Dr. Resasco’s pioneering work in sulfur tolerant catalysts and nanotechnology resulted in the first method for making carbon nanotubes in commercial quantities.

Surface Technology

We represent international chemical companies such as SDC Technologies Inc., a world leader in the development and manufacturing of polymeric high-performance abrasion resistant coating systems for application to plastic and glass materials. Dunlap Codding helped SDC develop patent portfolios involving several chemical arts such as nanotechnology, material sciences, and state of the art functional surface coating technologies. SDC’s considerable patent portfolio secured its position as a world-wide industry leader providing the chemical marketplace with enhancements required for the materials of tomorrow.

Polymers

We work extensively with clients involved with polymers, polymeric coating compositions and resinous compositions having enhanced color, optical clarity, thermal shock, and impact resistance. Dunlap Codding obtained patent protection for Dr. William Franks’ innovative methods for polymerizing soybean oil. Dr. Franks’ methods led to the development of the first commercially available one hundred percent soybean oil based inks. Dunlap Codding also has expertise in the areas of petrochemicals and water repellent compositions for cellulose containing materials.

Environmental & Green Technologies

We have procured patent rights in various fields of environmental science. Dunlap Codding obtained patents for one of the first water-based inks that is completely free of volatile organic compounds. These inks are water-resistant upon curing and can be printed on polymer films. The inks have won numerous awards and accolades for the impact they have had on environmental quality and safety. Dunlap Codding was also privileged to successfully prosecute the patent that protects the state of the art technology for using sophisticated surfactants to remediate underground pollution. This new technology may also revolutionize the household detergent industry.

The challenges inherent in the specialized field of procuring and protecting chemical intellectual property rights mandate working with legal experts who are well versed in the chemical arts. Our diverse and knowledgeable team of patent attorneys and agents includes former research chemists with extensive chemical background at the doctoral level, a wealth of scientific knowledge gained from industry experience and a former corporate patent general counsel having responsibility for a chemical subsidiary of a major corporation.

Life Sciences

We provide the insight and practical advice required by innovative companies to compete effectively in the marketplace.

Over the past 20 years, life sciences, biotechnology, and pharmaceutical ventures set new records for research and capital investment. Just as the life sciences are the building blocks of life itself, new biotechnologies consistently push the intellectual property envelope, requiring highly specialized and focused representation. Dunlap Codding assists many of these emerging growth companies in the development of their business plans, as well as securing strategic life science patent portfolios that are used for offense as well as defense.

Our life sciences and pharmaceutical practice has grown with the evolving needs of our clients. This evolution is evident in the increased number of Ph.D. level scientists moving into the field of patent prosecution. Along with our experienced patent professionals, top caliber technical advisors having varied academic and industry backgrounds complete our Life Sciences and Pharmaceuticals Practice Group.

Our proficiencies are a reflection of our extensive legal and scientific backgrounds including Doctorate and other advanced degrees in Chemistry, Botany, Plant Physiology, Population, Biochemistry and Molecular Biology. We have also served as adjunct faculty members at several universities including the University of Oklahoma Health Sciences Center and Oklahoma City University School of Law.

Our clients benefit from our professionalism, efficiency, and devotion to their individual intellectual property needs. We provide advice and counseling to medical and biotechnology companies including high-tech startups, university laboratories, research institutions, and established biotechnology pioneers.

We provide the personal attention that results in successful patent portfolios. Dunlap Codding’s expertise extends into all areas of biotechnology including glycobiology, biochemistry, immunology, microbiology, virology, genetics, developmental biology, cell biology, molecular biology, pharmaceutical compositions, molecular diagnostics and techniques, and medical devices and equipment.

A Strategic Partnering Example—Medical Devices/Biotechnology
For a client with a medical device designed to maintain blood flow, we performed a complete state of the art search, analyzing more than 300 references. The current “map” contains more than 1,000 references—patent, technical, and literature.

  • We brainstormed with engineering, legal, business and marketing teams to develop a hierarchy of chokepoints and “white space.”
  • We facilitated innovation strategy meetings and currently maintain an online and proprietary database including visualization tools focused on the information collected and analyzed.
  • We helped the client develop a patent strategy with a specific goal of market entry.  Market entry was achieved within 18 months of project initiation.
Additional highlights of include:
Cutting Edge Biotechnology

We were instrumental in securing intellectual property protection for the first process for producing individual endogenously loaded soluble HLA molecules and on the first recombinant methods for producing hyaluronic acid, chondroitin, and heparin. These patent portfolios have led to the creation of five biotechnology companies in several Oklahoma and Texas metroplexes.

We were instrumental in securing broad platform intellectual property protection for preconditioning and treatment of an intrinsic cardiac nervous system using an implantable electrical stimulus.

Immunology

We secured pioneering intellectual property protection for the first process for producing individual endogenously loaded soluble major histocompatibility complex (MHC) molecules. Our deep experience and skill in this area also extends to methods and processes for producing T Cell Receptor-mimics (TCRm) and the use of such mimics for the creation of peptides and antibodies for use in vaccines as well as assaying the potency of vaccines. We are pleased to have represented more than 12 U.S. and/or international companies in the field of immunology and we prosecute more than 100 patent applications worldwide per year on immunology-linked inventions.

We also have specific knowledge and experience in the areas of immune modulation, including the induction of targeted immune responses and the induction of specific immune tolerance, and antibody removal for transplantation technologies.

Oncology

We treat the field of oncology with a multi-disciplinary approach. Most biochemical inventions either have or hope to have some impact on the field of oncology. As such, our approach is to create a team of professionals with diverse backgrounds who can effectively and proactively protect a client’s oncology innovations. For example, we prosecuted and obtained the patent portfolio covering the fire recombinant methods for producing hyaluronic acid, chondroitin, and heparin. These glycosaminoglycans show excellent promise for oncological applications and we have extended the portfolio to cover their use as therapeutic and diagnostic tools. Additionally, many of our immunology clients perform research in the field of oncologic therapeutics—including the use of antibodies, cytolytic delivery of peptides, or conjugates for the targeting and treatment of specific forms of cancer, as well as other methods of upregulating the immune system to recognize cancerous cells as foreign. We are also experienced in diagnostic oncologic technologies, including the use of biomarkers and other diagnostic platforms for identification, progression, metastasis and prognosis.